Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
A randomized, Open-label phase III treatment trial to study the efficacy and safety of Crizotinib vs Cisplatin + Pemetrexed vs Carboplatin + Pemetrexed in 343 enrolled patients with Non-Small-Cell Lung Carcinoma (NSCLC) (ALK m)
Progression-Free Survival (PFS)
Overall Survival (OS)
The final analysis of the PROFILE 1014 study provides a new benchmark for OS in patients with Non-Small-Cell Lung Carcinoma (NSCLC) (ALK m) an…